D. S. Harry

434 total citations
16 papers, 357 citations indexed

About

D. S. Harry is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D. S. Harry has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D. S. Harry's work include Liver Disease Diagnosis and Treatment (10 papers), Cholesterol and Lipid Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). D. S. Harry is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Cholesterol and Lipid Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). D. S. Harry collaborates with scholars based in United Kingdom, United States and Mexico. D. S. Harry's co-authors include Neil McIntyre, A. J. G. Pearson, Richard N. Bergman, Yolanta T. Kruszynska, R. C. Day, Harold P. Morris, James S. Owen, A Y Foo, Walter Gratzer and David J. Brown and has published in prestigious journals such as Journal of Clinical Investigation, Gut and Journal of Lipid Research.

In The Last Decade

D. S. Harry

15 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. S. Harry United Kingdom 11 166 137 94 81 71 16 357
Gerard J. Davis United States 11 77 0.5× 86 0.6× 81 0.9× 65 0.8× 81 1.1× 21 371
Hidenari Takasan Japan 14 277 1.7× 266 1.9× 136 1.4× 244 3.0× 103 1.5× 30 578
Christopher Vickers Australia 10 185 1.1× 167 1.2× 107 1.1× 207 2.6× 42 0.6× 13 513
Anca Zimmermann Germany 13 158 1.0× 106 0.8× 150 1.6× 116 1.4× 113 1.6× 31 615
Kazuhide Takata Japan 10 178 1.1× 239 1.7× 120 1.3× 139 1.7× 63 0.9× 54 577
K Iesato Japan 13 78 0.5× 48 0.4× 51 0.5× 86 1.1× 29 0.4× 29 364
Linda Lewis United States 7 84 0.5× 103 0.8× 124 1.3× 31 0.4× 124 1.7× 8 415
K Miyai Japan 13 74 0.4× 120 0.9× 159 1.7× 47 0.6× 208 2.9× 36 518
Maria Piera Panozzo Italy 15 94 0.6× 253 1.8× 178 1.9× 51 0.6× 269 3.8× 38 471
Kalpna Desai United Kingdom 8 50 0.3× 109 0.8× 34 0.4× 26 0.3× 65 0.9× 15 345

Countries citing papers authored by D. S. Harry

Since Specialization
Citations

This map shows the geographic impact of D. S. Harry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. S. Harry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. S. Harry more than expected).

Fields of papers citing papers by D. S. Harry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. S. Harry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. S. Harry. The network helps show where D. S. Harry may publish in the future.

Co-authorship network of co-authors of D. S. Harry

This figure shows the co-authorship network connecting the top 25 collaborators of D. S. Harry. A scholar is included among the top collaborators of D. S. Harry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. S. Harry. D. S. Harry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lima, Vera Lúcia de Menezes, et al.. (1996). Characterization and potential uses of rabbit polyclonal antibodies against human plasma lecithin-cholesterol acyltransferase.. PubMed. 29(8). 957–68. 6 indexed citations
2.
Kruszynska, Yolanta T., D. S. Harry, Richard N. Bergman, & Neil McIntyre. (1993). Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia. 36(2). 121–128. 60 indexed citations
3.
Donald, Fiona, et al.. (1989). Non-Hodgkin's lymphoma and Hodgkin's lymphoma in the same patient.. Journal of Clinical Pathology. 42(4). 440–441. 1 indexed citations
4.
Harry, D. S., et al.. (1987). Severe Intrahepatic Cholestasis and Rapidly Progressive Renal Failure in a Patient with Immunocyte-Related Amyloidosis. Journal of Clinical Gastroenterology. 9(2). 219–222. 5 indexed citations
5.
Avgerinos, Alec, et al.. (1985). Lipid and Lipoprotein Response to a High Carbohydrate Diet in Parenchymal Liver Disease. Clinical Science. 69(s12). 65P–65P.
6.
Brown, David J., et al.. (1985). Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins.. Journal of Clinical Investigation. 76(6). 2275–2285. 43 indexed citations
7.
Goodall, Harry W., et al.. (1984). Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts.. Journal of Lipid Research. 25(9). 919–931. 22 indexed citations
8.
Owen, James S., et al.. (1981). Does the Abnormal Apoprotein Composition of High-Density Lipoprotein in Patients with Liver Disease Contribute to Their Anaemia?. Clinical Science. 60(3). 2P–2P. 1 indexed citations
9.
Day, R. C., D. S. Harry, James S. Owen, A Y Foo, & Neil McIntyre. (1979). Lecithin—Cholesterol Acyltransferase and the Lipoprotein Abnormalities of Parenchymal Liver Disease. Clinical Science. 56(6). 575–583. 32 indexed citations
10.
Harry, D. S., et al.. (1978). Lecithin—Cholesterol Acyltransferase and the Lipoprotein Abnormalities of Obstructive Jaundice. Clinical Science. 54(4). 369–379. 45 indexed citations
11.
Owen, James S., R A Hutton, Michael J. Hope, et al.. (1978). Lecithin:Cholesterol Acyltransferase Deficiency and Cell Membrane Lipids and Function in Human Liver Disease. Scandinavian Journal of Clinical and Laboratory Investigation. 38(sup150). 228–232. 10 indexed citations
12.
Harry, D. S., et al.. (1978). Plasma Lecithin:Cholesterol Acyltransferase Activity and the Lipoprotein Abnormalities of Liver Disease. Scandinavian Journal of Clinical and Laboratory Investigation. 38(sup150). 223–227. 14 indexed citations
13.
Carney, M. W. P., et al.. (1975). Self-induced colitis. Postgraduate Medical Journal. 51(594). 246–249. 11 indexed citations
14.
McIntyre, Neil, D. S. Harry, & A. J. G. Pearson. (1975). The hypercholesterolaemia of obstructive jaundice.. Gut. 16(5). 379–391. 50 indexed citations
15.
Harry, D. S., et al.. (1974). A simple method for liquid scintillation counting of weak β-emitting labelled lipids after separation by thin-layer chromatography. Clinica Chimica Acta. 50(3). 441–444. 18 indexed citations
16.
Harry, D. S., Harold P. Morris, & Neil McIntyre. (1971). Cholesterol biosynthesis in transplantable hepatomas: evidence for impairment of uptake and storage of dietary cholesterol. Journal of Lipid Research. 12(3). 313–317. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026